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Abstract
Background: GTF2I codes for a general intrinsic transcription factor and calcium channel regulator TFII-I, with high and 
ubiquitous expression, and a strong candidate for involvement in the morphological and neuro-developmental 
anomalies of the Williams-Beuren syndrome (WBS). WBS is a genetic disorder due to a recurring deletion of about 1,55-
1,83 Mb containing 25-28 genes in chromosome band 7q11.23 including GTF2I. Completed homozygous loss of either 
the Gtf2i or Gtf2ird1 function in mice provided additional evidence for the involvement of both genes in the craniofacial 
and cognitive phenotype. Unfortunately nothing is now about the behavioral characterization of heterozygous mice.
Methods: By gene targeting we have generated a mutant mice with a deletion of the first 140 amino-acids of TFII-I. 
mRNA and protein expression analysis were used to document the effect of the study deletion. We performed 
behavioral characterization of heterozygous mutant mice to document in vivo implications of TFII-I in the cognitive 
profile of WBS patients.
Results: Homozygous and heterozygous mutant mice exhibit craniofacial alterations, most clearly represented in 
homozygous condition. Behavioral test demonstrate that heterozygous mutant mice exhibit some neurobehavioral 
alterations and hyperacusis or odynacusis that could be associated with specific features of WBS phenotype. 
Homozygous mutant mice present highly compromised embryonic viability and fertility. Regarding cellular model, we 
documented a retarded growth in heterozygous MEFs respect to homozygous or wild-type MEFs.
Conclusion: Our data confirm that, although additive effects of haploinsufficiency at several genes may contribute to 
the full craniofacial or neurocognitive features of WBS, correct expression of GTF2I is one of the main players. In 
addition, these findings show that the deletion of the fist 140 amino-acids of TFII-I altered it correct function leading to 
a clear phenotype, at both levels, at the cellular model and at the in vivo model.
Background
Williams-Beuren syndrome (WBS) is among the most
compelling genetic disorders of human development and
behavior and is due to a recurring deletion of about 1,55-
1,83 Mb containing 25-28 genes in chromosome band
7q11.23 [1,2]. Individuals with WBS manifest characteris-
tic craniofacial dysmorphic features, cardiovascular
problems, mild to moderate mental retardation and mild
growth retardation [3]. The behavioral and cognitive pro-
file of WBS individuals is characterized by relatively pro-
ficient language and face-processing skills, but serious
impairments in visuo-spatial and numerical abilities. Per-
sonality traits include overfriendliness and charismatic
speech. Hyperacusis or algiacusis is an almost constant
feature. The roots of the mental and cognitive aspects of
WBS probably lie in disruption of normal neurodevelop-
ment, because brain morphology and neural organization
are abnormal [4]. A firm pathogenic mechanism has been
established for the cardiovascular problems that are
known to be caused by haploinsufficiency for the elastin
gene [5]. Additional candidates for involvement in several
aspects of the WBS phenotype have been proposed on
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Page 2 of 10the basis of clinical-molecular correlations in a few
patients with partial phenotypes and smaller deletions.
Two members of the GTF2I gene family, GTF2I and
GTF2IRD1, highly expressed during development and in
normal neuronal tissues, are strong candidates for the
craniofacial and some neurobehavioral features of WBS
[6-9]. Homozygous loss of either the Gtf2i or Gtf2ird1
function in mice provided additional evidence for the
involvement of both genes in the craniofacial and cogni-
tive phenotype. Mice with a heterozygous deletion of
exons 2-4 of Gtf2ird1 are less aggressive, more sociable
and possibly less anxious [10-12]. However, any pheno-
type identified in a model of total deletion can potentially
be assigned to the distal or the proximal half of the dele-
tion indicating that loss of genes in both half-deletions
may contribute to the phenotype [13]. Mouse models that
resemble the WBS genetically and phenotypically are
crucial to understand the roles haploinsufficient genes
play in development, cognition and behavior. A great deal
of information about possible functions of TFII-I has
been obtained recently [9,12,14]. However, despite all
these advances, the specific contribution of these genes to
the phenotype and the underlying pathogenic mecha-
nisms of the disease are not yet fully understood. Here,
we have studied the in vivo effects of an in frame deletion
of exon 2 of Gtf2i. The phenotypic characterization of
this mouse model confirms that any alteration in the cor-
rect function of TFII-I contribute to important features
displayed by WBS patients such as the craniofacial abnor-
malities and some neurobehavioral features including
hyperacusis.
Methods
Generation of Gtf2iΔex2 mutant mice
We have targeted Gtf2i in ES cells by a strategy consisting
in replacing exon 2 by a PGK-neo cassette (Figure 1A).
Detailed information regarding the generation of the tar-
geting vector as well as the PCR strategy to genotype
mice can be found in Additional file 1: Methods. Animals
were maintained under standard animal housing condi-
tions in a 12-h dark-light cycle with free access to food
and water. Animal care was in accordance with ethical
guidelines (European Communities Council Directive 86/
609/EEC) and approved by the Local Ethical Committee
(IMAS-IMIM/UPF).
Cell Culture and Immunocytofluorescence
We obtained and characterized MEFs following the pre-
viously described protocols [15]. All the experiments
were made by triplicate. Spontaneous immortalization
was carried out following a classical 3T3 protocol [16].
To detect endogenous and over-expressed TFII-I,
immunocytofluorescence was performed in primary
MEFs and transfected COS7 cells. After fixation and per-
meabilization, cells were stained with the specific
designed anti-TFII-I rabbit polyclonal antibodies.
Nuclear DNA was additionally stained with Hoechst
33258 (Molecular Probes). Microphotographs were taken
using an Olympus BXS1 microscope with an epifluores-
cence and phase-contrast optics equipped with the
Olympus DP71 camera and using the software CellB Digi-
tal Imaging system. A more detailed description can be
found in Additional file 1.
mRNA expression analysis
Total RNA from cells and tissue samples of mice was iso-
lated using the TRIZOL reagent (Invitrogen) or RNeasy
columns (Qiagen). Detailed protocols for RT-PCR analy-
sis and mRNA quantification elsewhere as primers
sequences are described in Additional file 1. Normaliza-
tion of values has been made using housekeeping genes
Actin and Hsp70. In all the cases, experiments were car-
ried out in triplicate to ensure reliability.
Protein analysis
Plasmids expressing mouse TFII-I wild type and
Δ140TFII-I (β-and Δisoforms) were generated using a
PCR-based strategy (TFIIWT and TFIIN140 as forward
primers and a common reverse primer TFIIR) (see
sequences in Additional file 1). PCR products were
cloned into the pcDNA3.1 Directional TOPO Expression
Kit (Invitrogen). Correct amplification of cloned prod-
ucts was tested by sequencing. Transient transfection of
COS7 cells was carried out using Fugene reagent (Roche).
Equal loading and transfer of samples were confirmed by
staining the membranes with Ponceau S. After blocking
with 3% BSA, membranes were incubated with the spe-
cific primary antibodies: anti-TFII-I; p21Cip1; p53 (Neo
Markers) and α-tubulin (Ab-1; Oncogene Research).
After incubation with the corresponding secondary anti-
bodies, ECL-plus kit (Amersham Pharmacia) was used to
visualize the protein.
Histology and immunohistochemstry
E6.5-7.5 deciduas or adult tissues were surgically
removed, fixed in 10% buffered formalin (Sigma), and
embedded in paraffin using standard procedures. Sec-
tions (6 μm) were stained with hematoxylin and eosin
(H&E). TUNEL assays were performed using the in situ
cell death detection kit (Roche). Cell proliferation was
determined by immunostaining with anti-Ki67 (Dako)
according to the manufacturer's instructions. Brains were
split into two hemispheres by a midsagittal section and
processed for stereology, according to the procedure
described previously [17]. More detailed description of
stereology analysis can be found in Additional file 1.
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Mutants and wild-type littermate mice were tested in a
battery of "primary screen" behavioral assays in the fol-
lowing order: wire hanging test, actimetry boxes, hot
plate, lit-dark box, tail immersion, elevated plus maze and
sound intolerance. The testing order was predetermined,
with less stressful tests conducted before more stressful
ones. The tests spam during 45 days with different time
intervals between tests. Additional batches of mice were
used for intruder test studies. Each batch of mice con-
sisted of 15 male mice per genotype to ensure sufficient
statistical power against variation of behavioral data.
More detailed description of behavioral tests can be
found in Additional file 1.
Figure 1 Structure and expression of the Gtf2iΔex2 mutant allele. A. Schematic genomic diagram of the targeting strategy. a. Partial restriction map 
of wild-type genomic DNA encompassing exons 1 (grey box), 2, 3, 4 and 5 of the Gtf2i locus (filled boxes) (B, BamHI; E, EcoRI; Bg, BglII); the translation 
initiator sites in the wild type (*) and targeted (**) alleles are indicated. The arrows indicate the location of the primers used for RT-PCR analysis. The 
targeting vector contains the PGK-neo (open box, neo) and lox511 sequences (filled triangle). Predicted targeting allele after homologous recombina-
tion. The stippled box indicates the location of the probe used for Southern blot analysis, recognizing EcoRI DNA fragments of 14,7kbp (wild-type al-
lele) and 9,7kbp (targeted allele). B. RT-PCR analysis. Using primers located in exons 1 and 4 (1) or 2 and 4 (2) of Gtf2i on mRNA from Gtf2i+/+, Gtf2i+/Δex2 
and Gtf2iΔex2/Δex2 mice. Transcripts lacking exon 2 are observed in heterozygous and homozygous mutant mice (1), while no amplicon was obtained 
with exon 2 and 4 primers in Gtf2iΔex2/Δex2 mice (2). C. Western blot analysis. Total protein extracts from MEFs (Gtf2i+/+ ; Gtf2i+/Δex2 and Gtf2iΔex2/Δex2) and 
COS7 cells transfected with a Gtf2iΔex2 cDNA lacking the first four exons were used for western blot analysis. We can observed that the truncated form 
present in Gtf2i+/Δex2 and Gtf2iΔex2/Δex2 extracts co-migrate with the artificial truncated form expressed in COS7 cells. D. Subcellular localization of en-
dogenous TFII-I in MEFs. The genotype of the cells is shown in the bottom. Equal nuclear localization of Δ140TFII-I and wild-type proteins was con-
firmed by DAPI staining in all cases. Scale bar: 10 μm.
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Data were analyzed using a one-way ANOVA with geno-
type as between subjects' factor followed by post hoc
comparisons (Tukey-Scheffé test) to detect statistical dif-
ferences among levels. The alpha-corrected level for all
tests was 0.05. All statistical tests were made under the R
environment.
Results
Gtf2iΔex2 mutant mice express a truncated TFII-I form
We have generated the Gtf2iΔex2 mutant mice using gene
targeting strategies. Exon 2 of Gtf2i was replaced by a
PGK-neo cassette (Figure 1A). Almost 4% of the clones
carried the correct mutation. Positive clones were aggre-
gated with CD1 morulae to generate chimeras. Germ-line
transmission was achieved by crossing chimeric males
with CD1 females and correct mutation transmission was
screened by Southern blot analysis.
RT-PCR analysis with primers located in the first and
fourth exons revealed that removal of exon 2 generated
an alternative shorter transcript (Figure 1B). Sequence of
this transcript confirmed the absence of exon 2. Western
blot analysis revealed that this transcript is translated in a
shorter form of TFII-I (Figure 1C). Since this truncated
form was recognized by the anti-TFII-I antibody, we
hypothesized that the deletion of exon 2 containing the
initiation codon abrogated to the use of a second in frame
start codon. In silico analysis (Netstart) identified a puta-
tive in frame translation initiation site with suitable
Kozak consensus sequence at exon 5, predicting a protein
lacking the first 140aa (Δ140TFII-I). We generated an
expression vector with a Gtf2i cDNA coding for such a
truncated Δ140TFII-I (exons 5 to 35), and expressed it in
COS7 cells. Figure 1C shows that the observed endoge-
nous truncated form in the Gtf2i+/Δex2 and Gtf2iΔex2/Δex2
mice co-migrated with the artificial truncated protein,
indicating that the ATG identified at exon 5 was indeed
used as the start codon for translation in the targeted
gene.
In vitro studies have shown that the deletion of the N-
terminal 90 amino acids of a TFII-I isoform does not
effect in the nuclear localization but affects its DNA
binding ability [18]. By immunocytochemistry, we
detected that both, endogenous and over-expressed
mutant Δ140TFII-I was localized preferentially in the
nucleus of primary MEFs and transfected COS7 cells
(Figure 1D). Co-existence of wild-type and mutant forms
does not affect their nuclear translocation. Both forms
showed a diffuse patter of fluorescence without the for-
mation of aggregates or any specific pattern distribution
into the nucleus. Surprisingly, ChIP analysis demon-
strates the ability of the truncated form to interact with
endogenous DNA target sequences (see Additional file 2).
Functional properties of the truncated TFII-I protein
We performed cotransfection followed by coimmunopre-
cipitation assays to evaluate if Δ140TFII-I form was able
to dimerize with wild-type TFII-I and also to interact
with known nuclear factors, as PARP1 [19]. As expected
wild-type TFII-I was able to co-immunoprecipitate itself
and PARP1, however, in the same conditions Δ140TFII-I
form was unable to co-immunoprecipitate either wild-
type TFII-I or PARP1 (see Additional file 2). These exper-
iments suggest that at least for some targeted pathways,
the truncated allele was working as a null allele.
Consequently, we attempted to test the transcriptional
properties of the Δ140TFII-I compared with the wild
type TFII-I protein by quantifying the endogenous and
exogenous mRNA levels from several genes (Cyclin D1, c-
fos, Luciferase, Gapdh, Hsp70, β-actin and Gtf2i) in
arrested or serum stimulated MEFs and COS7 cells trans-
fected with Δ140TFII-I-β or Δ140TFII-I-Δ constructs,
using murine TFII-I-β and TFII-I-Δ and human TFII-I-Δ
constructs as controls. Among the genes examined, c-fos
and Cyclin D1 contain canonical Inr elements on the pro-
moter region close to the transcription start sites and
have been previously reported as substrates for TFII-I
[20-22]. Expression of endogenous Cyclin D1 was
increased when cells were transfected with TFII-I-Δ but
not with the Δ140TFII-I-Δ form suggesting a lost of func-
tion for the truncated form at least for some of the
defined target-genes. Concerning the TFII-I-β constructs
we could not appreciate any significant expression
changes between genotypes, indicating a lack of signifi-
cant effect of TFII-I-β forms in the reported genes in the
cellular models used (see Additional file 3).
Growth properties of mutant mouse embryonic fibroblasts
Next, we decided to test whether Δ140TFII-I may modify
the direct link between mitogen-dependent signaling and
changes in nuclear gene expression that govern cellular
proliferation and cell division. Eleven independent fibro-
blast cultures derived from six different embryos were
grown following the classical 3T3 protocol to obtain fully
immortalized clones [16]. As illustrated in Figure 2A,
Gtf2iΔex2/Δex2 MEF cultures immortalized around eight
passages earlier than Gtf2i+/+ and Gtf2i+/Δex2 cultures
independently of the chosen immortalization pathway
(p53 dependent or not).
In order to abrogate any effect of immortalization path-
way in growth properties of cellular models, we per-
formed the next experiments in cultures immortalizes
following disruption of p53 pathway. Gtf2i+/Δex2 MEF cul-
tures did not growth at high density. Indeed, the number
of Gtf2i+/Δex2 cells in saturated cultures was 1.9 ± 1.5 × 106
per 10 cm dish (n = 3), whereas wild-type and Gtf2iΔex2/
Δex2 MEFs reached saturation levels that were two times
higher (3.8 ± 6.5 and 4.1 ± 0.15 × 106 per 10 cm dish, n =
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Page 5 of 103, respectively) (Figure 2B). Gtf2i+/Δex2 MEF cultures also
proliferated less efficiently than controls' (Figure 2C) and
had reduced plating efficiency opposite to the properties
shown by Gtf2iΔex2/Δex2 cultures. Whereas plating 4000
Gtf2i+/Δex2 MEFs in a Petri dish yielded only 21 ± 3.5 colo-
nies, the same amount of Gtf2i+/+ or Gtf2iΔex2/Δex2 MEFs
led to 114 ± 7.1 and 142 ± 4.2 colonies, respectively.
Finally, quiescent Gtf2i+/Δex2 MEFs re-entered the cell
cycle with normal kinetics upon serum stimulation (Fig-
ure 2D). However, the proportion of cells that entered to
the S phase was reduced by about 70% when compared
with Gtf2i+/+ or Gtf2iΔex2/Δex2 MEFs.
Homozygous mutant mice have highly reduced viability 
and fertility, and abnormal craniofacial morphology
The total absence Gtf2i is lethal in embryonic develop-
ment between E8.5 and E12.5 [12]. Abnormal Mendelian
frequencies of the expected genotypes in different crosses
were found at birth, with a clear reduction of Gtf2iΔex2/
Δex2 animals (Table 1). By contrast, surviving Gtf2iΔex2/Δex2
mice appeared to be grossly normal, indistinguishable
from their wild-type or heterozygous littermates. To
investigate the role of Gtf2iΔex2 mutation in mouse devel-
opment, we first analyzed the genotype frequencies of
embryos at 9.5-12.5 dpc. In contrasts to completed Gtf2i
KO mice, at 9.5 dpc dissected Gtf2iΔex2/Δex2 embryos were
morphologically indistinguishable of heterozygous or
wild-type littermates but were already underrepresented
from the expected Mendelian ratio (Table 1), suggesting a
much higher rate of early lethality. Histological examina-
tion of decidual swellings at E6.5-8 dpc revealed a signifi-
cant percentage of highly disorganized embryos with
gross morphological alterations [Normal/Abnormal =
58(72.5%)/22(27.5%)]. Only structures related to the ecto-
placental cone and trophoblast giant cells could be mor-
phologically identified (Figure 3A). Loss of the epiblast in
Figure 2 Growth properties of Gtf2iΔex2 mutant MEFs. A. Spontaneous immortalization. Eleven independent MEF cultures showing early immortal-
ization in Gtf2iΔex2/Δex2 and later in Gtf2i+/Δex2 cells. B. Saturation rate. 106 cells plated by triplicate and counted every three days until they reached the 
maximum score. A poorer saturation rate was observed in Gtf2i+/Δex2 cells. C. Proliferation of immortal MEFs. Three independent experiments were per-
formed with all cell types and each time point was done by triplicate. The fastest proliferation was observed in Gtf2iΔex2/Δex2 while Gtf2i+/Δex2 cells per-
formed the worst. D. Re-entry into S-phase after serum deprivation. The percentage of cells in S-phase was measured at the indicated times after 
serum stimulation. Again Gtf2i+/Δex2 MEFs showed the lowest rate of S-phase re-entry. Gtf2i+/+, open rhombus; Gtf2i+/Δex2 grey squares; Gtf2iΔex2/Δex2 
black triangles. All values are expressed as mean ± s.d.
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Page 6 of 10defective embryos appeared to be a consequence of
decreased cell proliferation, as determined by a marked
reduction of Ki67 immunostaining. No increased apopto-
sis was revealed by TUNEL staining despite that a signifi-
cant number of Gtf2iΔex2/Δex2 animals were lost before
E7.5 dpc (Figure 3A).
On physical exam, gross anatomy of mutant mice
appeared to be normal, with normal body size and
weight. However, in a 70-87% CD1 background a more
detailed evaluation revealed an obvious craniofacial phe-
notype in Gtf2iΔex2/Δex2 mice, more subtle in Gtf2i+/Δex2
animals, consisting in a shorter nose and wider nasal
Figure 3 Embryonic abnormalities and craniofacial dysmorphology in Gtf2iΔex2 mutant mice. A. H&E staining, Ki67 labeling and TUNEL assay. Sec-
tions from normal (top) and abnormal (bottom) E7.5 embryos derived from crosses between Gtf2i+/Δex2 females and Gtf2iΔex2/Δex2 males. Abnormal em-
bryos lacking detectable embryonic layers by H&E staining are likely to correspond to nonviable Gtf2iΔex2/Δex2 embryos. Normal embryos displayed high 
levels of Ki67-positive cells while they are no detectable in abnormal embryos. No differences were observed in the TUNEL staining. B. Morphologic 
abnormalities in Gtf2i mice at 8 weeks of age. (Left) The histogram shows the relative average distance from the tip of the nose to the proximal occipital 
suture (n = 10 per genotype). Pair wise comparisons revealed statistically significant differences between genotypes (Tukey test; P = 0.003 and P = 
0.048 for Gtf2iΔex2/Δex2 and Gtf2i+/Δex2 relative to Gtf2i+/+, respectively). (Right) representative photograph of the dissected cranial structure per genotype 
is shown. A shorter snout could be clearly appreciated in the Gtf2iΔex2/Δex2 mice. Gtf2i+/+, open; Gtf2i+/Δex2, grey; and Gtf2iΔex2/Δex2, black squares.
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Table 1: Genotypes' distribution during embryonic development and at birth
Mating Genotype
Male Female Age +/+ +/Δex2 Δex2/Δex2 P
Δex2/Δex2 +/Δex2 E8.5-E12.5 - 64 6 8.3 × 10-13
At Birth - 131 22 5.5 × 10-20
+/Δex2 +/Δex2 At Birth 167 340 48 3.7 × 10-18
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Page 7 of 10bridge (Figure 3B). Specific measurements of cranial
morphology (distance from the occipital suture to the tip
of the nasal bone) revealed significant differences among
genotypes (P = 0.004). These features are quite similar to
the craniofacial anomalies also present in the homozy-
gous Gtf2ird1 KO mice [10]. Despite the craniofacial
alteration, brain morphology appeared anatomically nor-
mal and brain weight is similar to wild-types or heterozy-
gous littermates. Because the WBS phenotype suggests
prominent functional alterations in the hippocampal
function, we searched for putative developmental neuro-
anatomical defects by stereological analysis of volumes
and total cell numbers. We analyzed global brain and
three areas of the hippocampus (CA1, CA3 and the den-
tate gyrus) in five adult male animals per genotype. No
significant abnormalities were observed in the mutant
animals with respect to the controls (data not shown).
During the normal breeding of the animals we
observed a reduced fertility period in both males and
females homozygous mutant mice. In both genders no
more than 4 consecutive litters were obtained with a pro-
gressive reduction in total pups (see Additional file 4).
Homozygous mother behavior was completely normal
and pup development is not affected. Anatomical exami-
nation of old mice reveal smaller and atrophy testis in the
80% of homozygous males analyzed but any anatomy
alteration that could explain affected fertility was
observed in ovaries or uterus of mutant females.
Behavioral alterations in adult Gtf2i+/Δex2 mice
To evaluate a possible involvement of TFII-I in the psy-
chomotor and neurobehavioral WBS phenotype, Gtf2i+/+,
Gtf2i+/Δex2 mice (n = 15 males per group) were evaluated
in several paradigms. Motor coordination (wire hanging),
locomotor activity (actimetry boxes and open-field) and
anxiety-related behaviors (lit-dark box; elevated plus
maze) were first explored. A significant decrease in the
vertical but not in horizontal locomotor activity (Figure
4A) was evident in Gtf2i+/Δex2 mice related to a decreased
exploratory activity despite normal motor coordination
(see Additional file 5).
Increased levels of anxiety were remarked in Gtf2i+/Δex2
mice in the different paradigms used. Statistical differ-
ences were observed in the elevated plus maze (decreased
percentage of entries and time in the open arms) (Figure
4B). In the open fild paradigm, no significant differences
could be reported probably due to a major dispersion of
results but we could observe a completed freezing of
heterozygous animals in the central zone (initial site to
the experiment) without any exploratory movement and
later on a minor number of entries in the central zone
suggesting all together a increase level of anxiety (Figure
4C). In the lit/dark box significant differences were found
in the increased latency of the first entry and in the
decreased number of entries, with the same tendency but
not significant shorter permanence in the lit compart-
ment (Figure 4D).
Sound intolerance was also measured by evaluating the
time of freezing behavior at different sound intensities.
Gtf2i+/Δex2 mice showed a significantly lower threshold
for sound intolerance, suggestive of the presence of algia-
cusis and/or hyperacusis already at 65 dB (Figure 4E).
No significant differences among genotypes were found
in thermal nociceptive thresholds (tail immersion and hot
plate tests), active avoidance and social behavior
(intruder test) (see Additional file 5).
In summary, a significant phenotype was obvious in
Gtf2i+/Δex2 animals with decreased exploratory activity,
higher anxiety and a lower threshold for sound intoler-
ance.
Discussion
In an attempt to create mouse models for WBS, we have
generated a mutant mouse with an in frame deletion of
exon 2 of Gtf2i resulting in the expression of a short TFII-
I protein lacking the initial 140 amino acids that could
function in some pathways as a lost of function allele. A
remarkable neurobehavioral phenotype was evident in
heterozygous mutant animals consisting in decreased
exploratory activity despite normal motor coordination,
enhancer anxiety and a low threshold for sound intoler-
ance. Homozygous mutants showed a reduced viability
early in development, with death before E8.5. However,
the small proportion of surviving Gtf2iΔex2/Δex2 mice, only
8% developed normally to adulthood with normal pre and
postnatal growth. Our findings indicate that complete
TFII-I activity is essential for cell proliferation during
early embryogenesis and that such requirement can be
only partially compensated in a small percentage of cases,
possibly by other TFII-I family members. However, com-
plete TFII-I activity seems not necessary for late fetal and
postnatal development although its deficiency leads to
specific neurological features.
Heterozygous Gtf2i+/Δex2 MEFs proliferated well, but
their growth rates were significantly slower and failed to
growth dense cultures when compared to wild-type and
homozygous Gtf2iΔex2/Δex2 cells. Moreover, quiescent
Gtf2i+/Δex2 MEFs did not re-enter the cell cycle upon
mitogenic stimuli as efficiently as their normal counter-
parts, suggesting a signaling defect mediated by the TFII-
I-containing higher-order protein complexes. Therefore,
we propose that the presence of the Δ140TFII-I protein
leads to an abnormal composition of the TFII-I com-
plexes with different consequences in the heterozygous or
homozygous state. The leucine zipper motif is required
for controlling the extent of complex formation and con-
sequently its nuclear function [21]. Our results under-
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I in appropriate stoichiometric concentrations.
Based on clinical-molecular correlations in patients
with partial deletions, GTF2I and GTF2IRD1 have been
proposed as strong candidates for the craniofacial and
some neurological features of WBS, while CYLN2 is
thought to contribute to the neurological and cognitive
phenotype [6-8]. Mouse models support these hypothe-
ses. Cyln2-/- and Cyln2+/- mice present with mild struc-
tural brain abnormalities, hippocampal dysfunction, and
deficits in motor coordination [23]. Three targeted
Gtf2ird1 and one Gtf2i mice have been reported. The
clear role of Gtf2ird1 in craniofacial abnormalities is
clearly demonstrated in two of the models [10,12] while
the other displayed reduced aggression and natural fear
response, and increased social interaction combined with
impaired amygdale-based learning [11]. However, haplo-
insufficiency for CYLN2, GTF2IRD1 and ELN alone or in
combination cannot explain all the clinical features of
WBS [23]. We show here that the deficiency of TFII-I by
ablation of the first 140 amino acids in mice results in a
characteristic phenotype related to the WBS features.
Gtf2i+/Δex2 and Gtf2iΔex2/Δex2 mice display craniofacial
abnormalities, with a shorter but symmetric snout and
apparent midface hypoplasia. Interesting, haploinsuffi-
ciency of both Gtf2i and Gtf2ird1 does not result in addi-
tive or synergistic effects in craniofacial phenotype [13]
as we could suppose due the fact that TFII-I and BEN
share functional domains and expression patterns and are
known to interact to each other. However, it is possible
that a phenotype seen in the single-gene mutant could be
modified in the deletion model due to complementary
elects of the other genes in the deletion.
Most WBS individuals show odynacusis along with
auditory allodynia; true hyperacusis, meaning a lowered
hearing threshold, and auditory fascinations are also
Figure 4 Neurobehavioral phenotype. A. Locomotor activity. A decrease in the vertical but not in horizontal locomotor activity measured in the ac-
timetry box was observed in Gtf2i+/Δex2 mice (P = 0.03). B. Elevated Plus Maze. Higher anxiety level was manifested in the Gtf2i+/Δex2 indicated by the 
reduced percentage of entries in the open arms (P = 0.001) and in the time spent in open arms (P = 0.0089). C. Open Field . Histograms represent 
latency (in seconds) and the number of entries in central zone. D.Lit/dark box. Gtf2i+/Δex2 mice showed a higher anxiety level revealed by increased 
latency of the first entry (P = 0.01), the lower activity (P= 0.02) and the time spent into the lit compartment. E. Acoustic sensitivity. Enhanced sensi-
tivity to an acute tone of 2800 Hz emitted at 65dB was observed in Gtf2i+/Δex2 mice demonstrated by a longer lasting freezing behavior (P = 0.01). Freez-
er response was similar between genotypes at 85, 105 and 125 dB confirming a plateau of response.
Gtf2i+/+, open; Gtf2i+/Δex2, grey squares. Each genotype groups are composed by males (n = 15). All values are expressed as mean ± s.d.
$
  




%&




&
'
&





 (  (  (






)




%

	
*
+
 (






$&






 ,-
 





.&



 $&
















 ,-












.&
 $&

Lucena et al. BMC Medical Genetics 2010, 11:61
http://www.biomedcentral.com/1471-2350/11/61
Page 9 of 10present although only in 5-10% of cases [24]. The origin
of these highly penetrant auditory symptoms in WBS is
not yet understood. The normal speech discrimination
and the lack of abnormal loudness growth function in
electrophysiological studies suggested abnormalities in
central auditory processing [25]. Very recently, Li and col-
laborators demonstrate that mice with a half proximal
deletion, including Gtf2i (PD) recapitulates some of the
features of WBS patients like, social interaction pheno-
type or abnormal sound sensitivity [13]. Until this work,
no behavioral phenotypes in Gtf2i mutant mice have
been reported. Here we demonstrate that the encoded
TFII-I molecule is a mean player in the abnormal sound
sensitivity phenotype. Gtf2i+/Δex2 animals showed clear
odynacusis, manifested by a lowered pain threshold for
loud sound (evident at 65dB), thus indicating that dele-
tion of GTF2I is likely responsible for the similar auditory
phenotype in WBS.
Conclusions
Our observations in the Gtf2iΔex2 mouse models illustrate
that GTF2I associates with some of the main phenotypic
features of WBS. A remarkable neurobehavioral pheno-
type consisting in decreased exploratory activity despite
normal motor coordination, enhancer anxiety and a low
threshold for sound intolerance was evident in heterozy-
gous mutant animals. As shown by previous studies in
human and mouse, no single gene appears to be responsi-
ble for all the craniofacial or neurocognitive features of
WBS [3,6-8,10-12,23]. Instead, additive effects of haplo-
insufficiency at several genes appear to be required, and
we propose that GTF2I is one of the main players. Our
data strongly suggest that the N-terminus of TFII-I is
essential for formation of higher-order protein com-
plexes, thus playing an important role in the final func-
tions of TFII-I in development and neurocognition.
Additional material
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
Conceived and designed the experiments, analyzed the results and wrote the
manuscript: VC, LPJ. Performed the experiments: Molecular and cellular biology
and histology: JL, SP, MS, MZ, VC. Targeting vectors: MCV, LPJ. Mouse genera-
tion, maintenance and genotyping: JL, SP, CC, IB, JLB. Behavioral phenotype: EA,
JL, RM. Mouse pathology: PD. Stereological analysis of the hippocampus: AS,
NS. All authors read and approved the final manuscript.
Acknowledgements
We thank Esther Barnadas, Verena Terrado for technical assistance. We are 
indebted to the Service of Pathology of the Hospital del Mar (Dr. S. Serrano) for 
making the facilities available to us. This work was supported by grants from 
the Spanish Ministry of Health (FIS 04/0433, to VC), the Spanish Ministry of Sci-
ence and Education (SAF2004-6382, to LPJ and BFU2006-04406/BMC, to JLB) 
and the VI Framework Programme of the European Union (LSHG-CT-2006-
037627, to LPJ). JL was supported by a FPI Fellowship (SAF2001-3941) and VC is 
a FIS Investigator.
Author Details
1Genetics Unit, de Ciències Experimentals i de la Salut, Universitat Pompeu 
Fabra, Barcelona, Spain, 2Laboratory of Neuropharmacology, Departament de 
Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, 
Spain, 3Beckman Institute, University of Illinois at Urbana Champaign, Urbana, 
USA, 4Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, 
Spain, 5Histologie et Pathologie Moleculaire, University of Bordeaux 2, 
Bordeaux, France, 6Life and Health Sciences Research Institute, University of 
Minho, Braga, Portugal, 7Centro de Investigación Biomédica en Red en 
Enfermedades Raras (CIBERER), Spain, 8Department of Cell Biology and 
Development, Centro de Investigaciones Biológicas, Madrid, Spain and 
9Program in Molecular Medicine and Genetics, Hospital Universitari Vall 
d'Hebron, Barcelona, Spain
References
1. Bayes M, Magano LF, Rivera N, Flores R, Perez Jurado LA: Mutational 
mechanisms of Williams-Beuren syndrome deletions.  American journal 
of human genetics 2003, 73(1):131-151.
Additional file 1 Methods. A more detailed description of methodology 
employed to develop the project.
Additional file 2 Figure S5.-DNA binding and protein-protein interac-
tion. A. ΔTFII-I binds DNA. PCR amplification from chromatine immunopre-
cipitated with anti-TFII-I Ab. ChIP assays were performed into wild-type, 
heterozygous and homozygous MEFs. A specific band is amplified corre-
sponding to Birc1F promoter. No amplification was observed in the IgG 
immunoprecipitates of in the negative control Renl. B. TFII-I does not 
dimerize with ΔTFII-I. Whole-cell lysates of cotransfected COS7 were sub-
jected to IP with anti-V5 Ab. Immunoprecipitates were detected with anti 
GST Ab (upper panel). Cell lysates of transfected wild-type and heterozy-
gous MEFs were subjected to GST pulldown assays. Levels of endogenous 
TFII-I forms were detected by immunobloting with anti-TFII-I Ab (lower 
panel). C. PARP1A does not immunoprecipitate with ΔTFII-I. Whole-cell lysates 
of cotransfected COS7 were subjected to IP with anti-V5 Ab. Immunopre-
cipitates were detected with anti GST Ab
Additional file 3 Figure S6 -mRNA expression in in vitroassays. A. Rela-
tive levels of mRNAs Histogram representing the relative levels of mRNA 
expression of different genes (white, Gapdh; grey, Gtf2i; striped, Cyclin D; 
punctated, c-fos; black, luciferase under control of c-fos promoter) after 
transient transfection of COS7 with plasmids expressing the indicated pro-
tein. mRNA levels have been normalized respect to expression levels pre-
sented by a mock transfected COS7 cells. Note the increase expression of 
Gtf2i after transfection. Only in positive control (cells transfected with plas-
mid expressing human GTF2I-Δ isoform) and in cells transfected with 
murine GTF2I-Δ isoform we could observe 4-fold increased expression for 
Cyclin D1. All the assays have been made by triplicate. B. Endogenous mRNA 
levels. Relative endogenous mRNA levels of indicated genes in Gtf2i+/+ 
arrested (black), Gtf2iΔex2/Δex2 arrested (striped), Gtf2i+/+ stimulated (grey) and 
Gtf2iΔex2/Δex2 stimulated (white) MEFs. We could not observe any difference 
between the conditions analyzed. All the assays have been made by tripli-
cate.
Additional file 4 Table S2: Homozygous mice Fertility
Additional file 5 Figure S7-Neurobehavioral phenotype. A. Motor coor-
dination. Any difference could be observed between wild-types and 
heterozygous mutant mice in all the parameters tested. B. Hot plate. The 
histogram represents the tail flick measured in seconds. C. Tail immersion. 
The histogram shows the time in seconds until the jumping D. Active avoid-
ance. No differences could be appreciated in the active avoidance test 
among genotypes. E. Social interaction. Resident-intruder tests. Any of these 
behavioral analysis reveled significant differences between genotypes. 
Gtf2i+/+ open square; Gtf2i+/Δex2, grey square. Each genotype groups are 
composed only by males (n = 15).
Received: 24 July 2009 Accepted: 19 April 2010 
Published: 19 April 2010
This article is available from: http://www.biomedcentral.com/1471-2350/11/61© 2010 Lucena et l; licensee BioMed Central Lt . is an Open Access articl  distributed under th  terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Genetic  2010, 11:61
Lucena et al. BMC Medical Genetics 2010, 11:61
http://www.biomedcentral.com/1471-2350/11/61
Page 10 of 102. Perez Jurado LA, Wang YK, Peoples R, Coloma A, Cruces J, Francke U: A 
duplicated gene in the breakpoint regions of the 7q11.23 Williams-
Beuren syndrome deletion encodes the initiator binding protein TFII-I 
and BAP-135, a phosphorylation target of BTK.  Human molecular 
genetics 1998, 7(3):325-334.
3. Perez Jurado AL: Williams-Beuren syndrome: a model of recurrent 
genomic mutation.  Hormone research 2003, 59(Suppl 1):106-113.
4. Meyer-Lindenberg A, Mervis CB, Berman KF: Neural mechanisms in 
Williams syndrome: a unique window to genetic influences on 
cognition and behaviour.  Nature reviews 2006, 7(5):380-393.
5. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, 
Keating MT: Elastin is an essential determinant of arterial 
morphogenesis.  Nature 1998, 393(6682):276-280.
6. Hirota H, Matsuoka R, Chen XN, Salandanan LS, Lincoln A, Rose FE, 
Sunahara M, Osawa M, Bellugi U, Korenberg JR: Williams syndrome 
deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on 
chromosome 7q11.23.  Genet Med 2003, 5(4):311-321.
7. Morris CA, Mervis CB, Hobart HH, Gregg RG, Bertrand J, Ensing GJ, 
Sommer A, Moore CA, Hopkin RJ, Spallone PA, et al.: GTF2I hemizygosity 
implicated in mental retardation in Williams syndrome: genotype-
phenotype analysis of five families with deletions in the Williams 
syndrome region.  American journal of medical genetics 2003, 
123A(1):45-59.
8. Edelmann L, Prosnitz A, Pardo S, Bhatt J, Cohen N, Lauriat T, Ouchanov L, 
Gonzalez PJ, Manghi ER, Bondy P, et al.: An atypical deletion of the 
Williams-Beuren syndrome interval implicates genes associated with 
defective visuospatial processing and autism.  Journal of medical 
genetics 2007, 44(2):136-143.
9. Dai L, Bellugi U, Chen XN, Pulst-Korenberg AM, Jarvinen-Pasley A, Tirosh-
Wagner T, Eis PS, Graham J, Mills D, Searcy Y, et al.: Is it Williams 
syndrome? GTF2IRD1 implicated in visual-spatial construction and 
GTF2I in sociability revealed by high resolution arrays.  American journal 
of medical genetics 2009, 149A(3):302-314.
10. Tassabehji M, Hammond P, Karmiloff-Smith A, Thompson P, Thorgeirsson 
SS, Durkin ME, Popescu NC, Hutton T, Metcalfe K, Rucka A, et al.: GTF2IRD1 
in craniofacial development of humans and mice.  Science 2005, 
310(5751):1184-1187.
11. Young EJ, Lipina T, Tam E, Mandel A, Clapcote SJ, Bechard AR, Chambers J, 
Mount HT, Fletcher PJ, Roder JC, et al.: Reduced fear and aggression and 
altered serotonin metabolism in Gtf2ird1-targeted mice.  Genes, brain, 
and behavior 2008, 7(2):224-234.
12. Enkhmandakh B, Makeyev AV, Erdenechimeg L, Ruddle FH, Chimge NO, 
Tussie-Luna MI, Roy AL, Bayarsaihan D: Essential functions of the 
Williams-Beuren syndrome-associated TFII-I genes in embryonic 
development.  Proceedings of the National Academy of Sciences of the 
United States of America 2009, 106(1):181-186.
13. Li HH, Roy M, Kuscuoglu U, Spencer CM, Halm B, Carlsmith Harrison K, 
Bayle JH, Splendore A, Ding F, Meltzer LA, et al.: Induced chromosome 
deletions cause hypersociability and other features of Williams-Beuren 
Syndrome in Mice.  EMBO Molecular Medicine 2009, 1:50-65.
14. Roy AL: Signal-induced functions of the transcription factor TFII-I.  
Biochimica et biophysica acta 2007, 1769(11-12):613-621.
15. Pantoja C, Serrano M: Murine fibroblasts lacking p21 undergo 
senescence and are resistant to transformation by oncogenic Ras.  
Oncogene 1999, 18(35):4974-4982.
16. Todaro GJ, Green H: Simian virus 40 transformation and the period of 
cellular deoxyribonucleic acid synthesis.  J Virol 1967, 1(1):115-119.
17. Keuker JIV-HGaFE: How to use the optical fractionator:an example 
based on the estimation of neurons in the hippocampal CA1 and CA3 
regions of tree shrews.  Brain Res Protoc 2001, 7:211-221.
18. Cheriyath V, Roy AL: Structure-function analysis of TFII-I. Roles of the N-
terminal end, basic region, and I-repeats.  J Biol Chem 2001, 
276(11):8377-8383.
19. Tapia-Paez I, Tammimies K, Massinen S, Roy AL, Kere J: The complex of 
TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated 
in neuronal migration and dyslexia.  Faseb J 2008, 22(8):3001-3009.
20. Roy AL: Biochemistry and biology of the inducible multifunctional 
transcription factor TFII-I.  Gene 2001, 274(1-2):1-13.
21. Hakre S, Tussie-Luna MI, Ashworth T, Novina CD, Settleman J, Sharp PA, 
Roy AL: Opposing functions of TFII-I spliced isoforms in growth factor-
induced gene expression.  Mol Cell 2006, 24(2):301-308.
22. Desgranges ZP, Ahn J, Lazebnik MB, Ashworth T, Lee C, Pestell RC, 
Rosenberg N, Prives C, Roy AL: Inhibition of TFII-I-dependent cell cycle 
regulation by p53.  Mol Cell Biol 2005, 25(24):10940-10952.
23. van Hagen JM, Geest JN van der, Giessen RS van der, Lagers-van Haselen 
GC, Eussen HJ, Gille JJ, Govaerts LC, Wouters CH, de Coo IF, Hoogenraad 
CC, et al.: Contribution of CYLN2 and GTF2IRD1 to neurological and 
cognitive symptoms in Williams Syndrome.  Neurobiol Dis 2007, 
26(1):112-124.
24. Levitin DJ, Cole K, Chiles M, Lai Z, Lincoln A, Bellugi U: Characterizing the 
musical phenotype in individuals with Williams Syndrome.  Child 
Neuropsychol 2004, 10(4):223-247.
25. Hickok G, Bellugi U, Jones W: Asymmetrical ability.  Science 1995, 
270(5234):219-220.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2350/11/61/prepub
doi: 10.1186/1471-2350-11-61
Cite this article as: Lucena et al., Essential role of the N-terminal region of 
TFII-I in viability and behavior BMC Medical Genetics 2010, 11:61
